About the Event
Cambridge Healthtech Institute's Fifth Annual Clinical Trial Innovation Summit will bring together leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. The 2016 program focuses on key issues and opportunities in the clinical trial industry, including Patient Recruitment, Site Selection, Data Integration, Existing Data Sources, Mobile Tech, Project Management, Outsourcing, Vendor Management, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring and Clinical Auditing.
Additional Opportunities to Learn & Collaborate
Dinner Course - Meeting the Customers’ Needs. What Are the Expectations of Risk-Based Monitoring?
What’s New in 2016
A Fresh Focus on Vendor Performance and Quality
Dedicated Programming for Small and Mid-Sized Pharma/Biotech
Lessons Learned on Risk-Based Monitoring from Companies Further Ahead in Implementing RBM
Discussion of New and Emerging Tech across Pharma for Clinical Trials
In-Depth Coverage of Secondary Data Use, Data Sharing and Data Privacy
Vice President, Global Study Operations, Amgen
Vice President, Global R&D Quality, Allergan
Executive Director, Global Clinical Trial Operations IT, Merck
Director, Development Operations, Contracts
& Outsourcing Vendor Management Lead, Astellas
Senior Director, Portfolio & Vendor Quality, Pfizer